- Home
- RWAY vs ZVRA Comparison
RWAY vs ZVRA Comparison
Compare RWAY & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RWAY
- ZVRA
- Stock Information
- Founded
- RWAY 2015
- ZVRA 2006
- Country
- RWAY United States
- ZVRA United States
- Employees
- RWAY N/A
- ZVRA N/A
- Industry
- RWAY
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- RWAY
- ZVRA Health Care
- Exchange
- RWAY Nasdaq
- ZVRA Nasdaq
- Market Cap
- RWAY 395.5M
- ZVRA 381.0M
- IPO Year
- RWAY 2021
- ZVRA 2015
- Fundamental
- Price
- RWAY $9.17
- ZVRA $7.31
- Analyst Decision
- RWAY Buy
- ZVRA Strong Buy
- Analyst Count
- RWAY 7
- ZVRA 8
- Target Price
- RWAY $11.57
- ZVRA $22.29
- AVG Volume (30 Days)
- RWAY 538.4K
- ZVRA 474.8K
- Earning Date
- RWAY 05-13-2025
- ZVRA 05-07-2025
- Dividend Yield
- RWAY 13.15%
- ZVRA N/A
- EPS Growth
- RWAY 73.09
- ZVRA N/A
- EPS
- RWAY 1.89
- ZVRA N/A
- Revenue
- RWAY $144,632,000.00
- ZVRA $23,612,000.00
- Revenue This Year
- RWAY N/A
- ZVRA $267.44
- Revenue Next Year
- RWAY N/A
- ZVRA $90.10
- P/E Ratio
- RWAY $4.86
- ZVRA N/A
- Revenue Growth
- RWAY N/A
- ZVRA N/A
- 52 Week Low
- RWAY $8.35
- ZVRA $4.20
- 52 Week High
- RWAY $13.50
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- RWAY 39.62
- ZVRA 49.75
- Support Level
- RWAY $8.83
- ZVRA $6.85
- Resistance Level
- RWAY $9.24
- ZVRA $7.27
- Average True Range (ATR)
- RWAY 0.43
- ZVRA 0.46
- MACD
- RWAY 0.02
- ZVRA 0.03
- Stochastic Oscillator
- RWAY 37.02
- ZVRA 75.17
About RWAY Runway Growth Finance Corp.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and Canada, with the majority of its portfolio invested in the United States.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.